COMPARATIVE BIOAVAILABILITY STUDY OF 3 SUSTAINED-RELEASE QUINIDINE FORMULATIONS

被引:7
作者
MAHON, WA
LEEDER, JS
BRILLEDWARDS, MM
CORREIA, J
MACLEOD, SM
机构
[1] HOSP SICK CHILDREN,DIV CLIN PHARMACOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
D O I
10.2165/00003088-198713020-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:118 / 124
页数:7
相关论文
共 11 条
[1]   RELATIVE BIOAVAILABILITY OF QUINIDINE GLUCONATE AND QUINIDINE SULFATE IN HEALTHY-VOLUNTEERS [J].
COVINSKY, JO ;
RUSSO, J ;
KELLY, KL ;
CASHMAN, J ;
AMICK, EN ;
MASON, WD .
JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (5-6) :261-269
[2]  
DRAYER DE, 1977, J LAB CLIN MED, V90, P816
[3]  
DRAYER DE, 1978, CLIN PHARMACOL THER, V24, P31
[4]  
MAHON WA, 1976, CLIN PHARMACOL THER, V19, P566
[5]   SINGLE AND MULTIPLE DOSE PHARMACOKINETICS OF ORAL QUINIDINE SULFATE AND GLUCONATE [J].
OCHS, HR ;
GREENBLATT, DJ ;
WOO, E ;
FRANKE, K ;
PFEIFER, HJ ;
SMITH, TW .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (04) :770-777
[6]   SIMULTANEOUS 1ST-ORDER AND ZERO-ORDER ABSORPTION OF CARBAMAZEPINE TABLETS IN HUMANS [J].
RIAD, LE ;
CHAN, KKH ;
WAGNER, WE ;
SAWCHUK, RJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (09) :897-900
[7]   FACTORS INFLUENCING CONVERSION OF CHRONIC ATRIAL FIBRILLATION WITH SPECIAL REFERENCE TO SERUM QUINIDINE CONCENTRATION [J].
SOKOLOW, M ;
BALL, RE .
CIRCULATION, 1956, 14 (04) :568-583
[8]  
UEDA CT, 1976, CLIN PHARMACOL THER, V20, P260
[9]  
UEDA CT, 1976, CLIN PHARMACOL THER, V19, P30
[10]  
UEDA CT, 1986, APPLIED PHARMACOKINE, P712